Skip to main content


25 Jan, 2017 Objective 3: MAG-CP Updates (December 2016 - January 2017)
The Canadian Perinatal Network (CPN) was a network of tertiary centres that aimed to improve care of high-risk women and infants born very preterm. Recently, the focus was on the managed knowledge translation (KT) project, MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP), jointly led by the Canadian Perinatal Network (CPN) (LA Magee) and the... Read More
25 Jan, 2017 Preeclampsia Foundation Initiates First Global Preeclampsia Day
To help build awareness of pre-eclampsia outside the United States, the Preeclampsia Foundation is partnering with other like-minded organizations to sponsor the first-ever World Preeclampsia Day on Monday, May 22, 2017. Planning is underway and involves multiple global advocacy and professional organizations including representatives from Australia, Brazil, Ireland, the... Read More
30 Nov, 2016 Objective 2: miniPIERS/fullPIERS Update (October-November 2016)
In partnership with LGT Medical, we have completed the development of a prototype mobile application called KENEK PIERS that combines the mini- and full-PIERS models into a single platform for care of hypertensive women in community or facility settings. This application has now been tested with a sample of target end-users from Canada, Brazil and India to determine its... Read More
30 Nov, 2016 Objective 3: STRIDER Updates (October - November 2016)
The STRIDER Canada trial is nearing activation. After approval from Health Canada, the recent acquisition and training received on the Alere® Triage Meters, test devices to measure PLGF levels, and shipment of study drugs for encapsulation and manufacturing of identical placebo capsules. The STRIDER Co-ordinating Centre is finalizing all the study and training documents... Read More
28 Nov, 2016 Objective 3: CLIP Trials Updates (October-November 2016)
As of the end of October 2016, the total number of pregnancies in the CLIP Trials is 75,582. We are happy to announce that the CLIP India Trial has completed recruitment as of 31 October 2016! This is truly a milestone, and we would like to acknowledge the hard work of the CLIP India research team - both at KLE University’s JNMC Team in Belgaum, and SNMC team in Bagalkot,... Read More
25 Nov, 2016 integrated System for Trial Allocation and Randomisation (iSTAR)
We are proud to announce our new platform, integrated System for Trial Allocation and Randomisation (iSTAR), which can be used  to streamline the processes of double-blind randomised controlled trials (RCT). iSTAR is mobile-friendly web-based platform developed by UBC PRE-EMPT. iSTAR was designed to be flexible so that it can be customised as per... Read More
25 Nov, 2016 Global Forum on Bioethics Research (GFBR) meeting on the ‘Ethics of Research in Pregnancy’
The Global Forum on Bioethics Research (GFBR) meeting on the ‘Ethics of Research in Pregnancy’ was held in Buenos Aires, Argentina from 3-4 November 2016. The meeting was well attended with participants from over 40 countries, including participation from several PRE-EMPT members, most notably Shivaprasad Goudar, from Jawaharlal Nehru Medical College, who served on the... Read More
25 Nov, 2016 Tom Easterling Wins ISSHP’s Chesley Award
The International Society for the Study of Hypertension in Pregnancy Chesley Award is given to a member of the Society in recognition of her/his sustained and substantial contribution to research in pre-eclampsia, not only for her/his work but also for encouraging the work of others. The winner is awarded with $1,000 and the Chesley plaque. This year Tom Easterling, Professor... Read More
25 Nov, 2016 Global Pregnancy Collaboration (CoLab): Updates (October- November 2016)
Photo: Roberto Araújo Costa, José Guilherme Cecatti, Marcos Antonio Santos, Wallace Mendes, Guilherme de Jesus, José Carlos Peracoli, Maria Laura Nascimento, Renato Teixeira, José Paulo Guida, Jim Roberts, Beth Payne, Sumedha Sharma, Bruna Silva, Angélica Rodrigues, Marcos Bastos Dias, Sérgio Toledo, Lucy Chappell, Lucilla Poston, Peter von Dadelszen, Laura Magee, and Arun... Read More
25 Nov, 2016 Objective 1: CAP Update (October - November 2016)
The CAP Study Women with a history of pre-eclampsia in their most recent pregnancy who agree to participate, receive calcium 500mg daily or placebo from enrollment until they become pregnant up to 20 weeks of pregnancy. The primary outcome is pre-eclampsia. CAP study progress We have entered the final phase of our study. We have been following-up with women recruited... Read More